Epidermolytic Ichthyosis
Also called Epidermolytic Hyperkeratosis (EHK) or Bullous Congenital Ichthyosiform Erythroderma (BCIE). Blistering improves with age; hyperkeratosis and odour become the main challenges.
Epidermolytic Ichthyosis is now also classified as KRT1-nEDD or KRT10-nEDD depending on which keratin gene is affected. Both names remain valid.
Prevalence: 1 in 200,000–300,000. Autosomal dominant inheritance (most cases). KRT1 and KRT10 genes encode suprabasal keratins.
Widespread erythroderma (redness), blistering, and skin denudation. Often resembles scalded skin. NICU admission common for barrier support.
Blistering reduces significantly. Thick, warty hyperkeratosis develops, especially in flexures. Odour becomes a major quality-of-life issue.
Palmoplantar keratoderma (PPK) — more severe with KRT1 mutations. KRT10 mutations generally have milder PPK and smoother scales.
Daily Routine
Morning routine takes 45–60 minutes. Non-negotiable for preventing buildup and infection.
- Short warm bath (15–20 min) with bath oil or emollient wash
- Gentle scale removal — avoid aggressive rubbing (increases blistering risk)
- Pat dry carefully — blisters form easily with friction
- Apply keratolytic (urea 10–20% or salicylic acid 3–6%) to thickest areas
- Full-body emollient (50:50 paraffin, Diprobase, or Epaderm ointment)
- Extra attention to flexures (armpits, groin, neck folds) — odour hotspots
- Acitretin with breakfast if prescribed (fat helps absorption)
- Dress in loose, breathable cotton clothing
Evening is the main therapeutic session. Allow 60 minutes minimum.
- 30–40 minute bath with bath oil (Oilatum Plus, Balneum Plus)
- Systematic scale removal — gentle but thorough, head to toe
- Focus on flexures: armpits, groin, neck, behind knees — bacteria accumulate here
- Apply keratolytic to warty areas (elbows, knees, scalp)
- Thick emollient to entire body immediately after bath
- Antiseptic wash (Dermol 500 or chlorhexidine) to odour-prone areas 2–3x weekly
- Change bedding frequently — scale accumulates overnight
Bathing is the cornerstone of EI management
- Frequency: Twice daily minimum (morning + evening). Some add midday bath in severe cases.
- Duration: 15–40 minutes depending on severity and age
- Temperature: Warm, not hot. Hot water worsens blistering.
- Bath additives: Emollient bath oil (Oilatum, Balneum, Cetraben) or bath-based emollient (Dermol 600)
- Scale removal: Soft sponge or washcloth. Gentle circular motions. Never scrub aggressively.
- Pat dry: Rubbing increases blister risk. Use soft cotton towels.
- Apply emollient immediately: Within 3 minutes of leaving bath — this locks in moisture
Product recommendations (UK examples — prescribable)
- 50:50 White Soft Paraffin + Liquid Paraffin (thick, greasy, effective)
- Epaderm Ointment (paraffin-based)
- Diprobase Ointment
- CeraVe Moisturising Cream (ceramide-based, less greasy option)
- Urea 10–20% cream (Eucerin, Balneum, Nutraplus)
- Salicylic acid 3–6% in emollient base (monitor in children — salicylate absorption risk)
- Lactic acid 5–12% lotions (less commonly used in UK)
- Oilatum Plus (antimicrobial + emollient)
- Balneum Plus (soya oil + antimicrobial)
- Dermol 600 Bath Emollient
- Cetraben Bath Additive
- Dermol 500 Lotion (antimicrobial emollient wash)
- Chlorhexidine wash 2–3x weekly to flexures
- Topical antibiotics (Fucidin cream) to infected or odorous areas
- Oral antibiotics (short courses for flare-ups)
Medication Options
| Drug | Role | Efficacy | Key Monitoring | Notes |
|---|---|---|---|---|
| Acitretin (low-dose) | Reduces hyperkeratosis and keratin aggregates | 75–85% | Liver, lipids, bone growth (children) | Especially effective for KRT10 mutations. Dose: 0.3–0.5mg/kg/day (lower than for other types). |
| Emollients (50:50 paraffin) | Hydration, barrier support | 80% | Fire risk warning required | Used in very large quantities — 500g+ weekly is common. |
| Topical keratolytics (urea, salicylic acid) | Scale reduction | 70% | Salicylate toxicity in children (if salicylic acid used extensively) | Helpful but can worsen blistering if overused. |
| Topical/oral antibiotics | Infection and odour management | Variable | Antibiotic resistance | Short courses only. Long-term use avoided where possible. |
| Antiseptic washes (chlorhexidine, triclosan) | Bacterial load reduction in flexures | 75% | Skin sensitivity | Regular use 2–3x weekly significantly reduces odour. |
Common Problems
Blistering (especially in infancy and childhood)
Why it happens: Mutations in KRT1/KRT10 cause keratin collapse → cells are fragile → friction creates blisters.
Management:
- Minimise friction: soft clothing, avoid tight shoes, cotton bedding
- Gentle bathing technique — no scrubbing
- Do not pop blisters unless infected or very painful
- Sterile drainage if needed: clean needle, antiseptic cream, non-stick dressing
- Monitor for infection: increased pain, redness, pus, fever
- Acitretin may reduce blistering frequency over time
Timeline: Blistering is worst in first years of life. Reduces significantly by adolescence. Hyperkeratosis becomes the dominant feature.
Odour (major quality-of-life burden)
Why it happens: Bacteria (especially Staphylococcus and Corynebacterium) colonise skin folds and thick scale. Warm, moist flexures are ideal bacterial environments.
Management:
- Twice-daily bathing with thorough flexure cleaning
- Antimicrobial bath oils (Oilatum Plus, Balneum Plus)
- Antiseptic washes (Dermol 500, chlorhexidine 4%) to armpits, groin, neck 2–3x weekly
- Topical antibiotics (Fucidin, Bactroban) to problem areas
- Short courses of oral antibiotics (flucloxacillin, erythromycin) during flare-ups
- Cotton clothing — synthetic fabrics trap bacteria
- Frequent clothing and bedding changes
Psychosocial impact: Odour is one of the most distressing aspects of EI. It affects school, work, relationships. Honest conversation with dermatologist is essential. This is a recognised medical problem, not a hygiene failure.
Skin infections
Why it happens: Compromised skin barrier + warm moist environment + bacterial colonisation = high infection risk.
Signs of infection:
- Increased redness, warmth, swelling
- Pus or yellow crusting
- Worsening odour
- Pain or tenderness
- Fever
Action: Contact dermatologist or GP same day. Skin swab to identify organism. Oral antibiotics typically required (topical often insufficient for widespread infection). Admit to hospital if systemically unwell or spreading cellulitis.
Palmoplantar keratoderma (PPK)
What it is: Thick, painful skin on palms and soles. More severe with KRT1 mutations.
Management:
- High-concentration urea cream (20–40%) to palms and soles daily
- Salicylic acid 6% ointment (use carefully — monitor for salicylate toxicity in children)
- Acitretin reduces PPK thickness significantly
- Regular podiatry input for foot care
- Custom orthotics if walking is painful
- Soft, cushioned footwear
Impact: PPK can make walking, gripping, and daily tasks painful. Occupational therapy input helpful for adaptations and aids.
8-Week Getting Started Protocol
If you're newly diagnosed or struggling with control, this 8-week structure helps establish a baseline routine.
Goal: Build the habit of twice-daily bathing and emollient application.
- Morning: 15–20 min bath + emollient + keratolytic to thickest areas
- Evening: 30–40 min bath + thorough scale removal + full emollient
- Track time and products used — helps identify what works
- Dermatology appointment: discuss acitretin if not already prescribed
Goal: Add antimicrobial strategies to reduce bacterial load.
- Switch to antimicrobial bath oil (Oilatum Plus or Balneum Plus)
- Add antiseptic wash (Dermol 500 or chlorhexidine) to flexures 2–3x weekly
- Apply topical antibiotic (Fucidin) to any persistently odorous or crusted areas
- Monitor for improvement in odour — if no change, discuss oral antibiotics with GP
Goal: Fine-tune keratolytic use and acitretin dose (if prescribed).
- Increase keratolytic concentration if scale still thick (e.g., urea 10% → 20%)
- If on acitretin, assess response — discuss dose adjustment with dermatologist if needed
- Focus on high-burden areas: scalp, flexures, palms/soles
- Consider adding lactic acid lotion to arms/legs if urea not sufficient
Goal: Lock in what works. Plan for maintenance and support.
- Review routine: what's working? What's still difficult?
- Dermatology review: blood tests (if on acitretin), reassess treatment plan
- Connect with Ichthyosis Support Group or FIRST for peer support
- Establish regular prescription routine — ensure you never run out of emollients/keratolytics
- Consider psychosocial support if odour or appearance is affecting mental health
Key Research & Gene Therapy
EI Cure Project — Active Gene Therapy Research
The EI Cure Project is a global research network specifically focused on developing gene therapy and molecular treatments for Epidermolytic Ichthyosis. This is not distant-future research — clinical trials are in active planning stages.
Visit EI Cure Project →How Acitretin Works (Li & Törmä 2024)
Low-dose acitretin reduces keratin aggregates (clumps of damaged keratin proteins) in the epidermis. This improves skin structure and reduces both hyperkeratosis and blistering. Published in Acta Dermato-Venereologica, 2024.
Real-World Cohort Data (Frommherz et al. 2025)
Study of 47 EI patients in JEADV (2025) confirmed skin pain, infections, and odour as the most burdensome symptoms. Quality of life significantly improved with acitretin and structured bathing protocols.
What to Expect Over Time
Infancy (0–2 years)
Blistering is severe. Erythroderma (whole-body redness) is common. Skin denudation (raw areas) frequent. NICU or paediatric dermatology input often required in first weeks/months. Barrier care is intensive.
Childhood (2–12 years)
Blistering reduces gradually. Hyperkeratosis (thick warty scale) develops, especially in flexures, scalp, and over joints. Odour becomes more prominent. School-age children often face social challenges. Acitretin typically started in this phase if not already prescribed.
Adolescence & Adulthood
Blistering is rare except with significant trauma. Hyperkeratosis is the dominant feature. Palmoplantar keratoderma (if KRT1) can be painful and functionally limiting. Odour management remains a priority. Mental health support important — appearance-related anxiety and social isolation are common.
Red Flags
- Widespread skin infection with fever (sepsis risk)
- Rapidly spreading cellulitis (red, hot, swollen skin advancing across body)
- Signs of sepsis: confusion, very high or very low temperature, rapid breathing, cold clammy skin
- Severe pain not controlled with usual analgesia
- Inability to walk due to foot blistering/infection (especially if diabetic or immunocompromised)
Connect with Others
EI Cure Project
Gene therapy research network. Clinical trial updates, patient registry, research participation opportunities.
eicureproject.com →Ichthyosis Support Group UK
UK-based support. Annual family conference, regional meetups, peer support network.
ichthyosis.org.uk →FIRST Foundation (USA)
Global network. Medical advisory board, camps, conferences, international connections.
firstskinfoundation.org →